| 0 |
Paramagnetic Contrast Agent [EPC] |
3 |
0.0007 |
| 1 |
Estrogen Receptor Antagonist [EPC] |
26 |
0.0006 |
| 2 |
Aromatase Inhibitor [EPC] |
24 |
0.0002 |
| 3 |
Prostaglandin E1 Analog [EPC] |
2 |
0.0001 |
| 4 |
Thiazide-like Diuretic [EPC] |
5 |
0.0001 |
| 5 |
Antifibrinolytic Agent [EPC] |
1 |
0.0001 |
| 6 |
Sulfone [EPC] |
1 |
0.0001 |
| 7 |
Calcium [EPC] |
9 |
0.0001 |
| 8 |
Dietary Cholesterol Absorption Inhibitor [EPC] |
5 |
0.0001 |
| 9 |
CD52-directed Cytolytic Antibody [EPC] |
1 |
0.0001 |
| 10 |
Serotonin-3 Receptor Antagonist [EPC] |
6 |
0.0000 |
| 11 |
Alkaloid [EPC] |
1 |
0.0000 |
| 12 |
Iron Chelator [EPC] |
1 |
0.0000 |
| 13 |
Serotonin Reuptake Inhibitor [EPC] |
3 |
0.0000 |
| 14 |
Histamine-2 Receptor Antagonist [EPC] |
4 |
0.0000 |
| 15 |
Sodium-Glucose Cotransporter 2 Inhibitor [EPC] |
3 |
0.0000 |
| 16 |
Proton Pump Inhibitor [EPC] |
15 |
0.0000 |
| 17 |
Polyene Antifungal [EPC] |
1 |
0.0000 |
| 18 |
RANK Ligand Inhibitor [EPC] |
5 |
0.0000 |
| 19 |
Aminosalicylate [EPC] |
2 |
0.0000 |
| 20 |
Expectorant [EPC] |
4 |
0.0000 |
| 21 |
Antirheumatic Agent [EPC] |
2 |
0.0000 |
| 22 |
Complement Inhibitor [EPC] |
1 |
0.0000 |
| 23 |
Opioid Agonist [EPC] |
4 |
0.0000 |
| 24 |
Tetracycline-class Drug [EPC] |
1 |
0.0000 |
| 25 |
HER2/neu Receptor Antagonist [EPC] |
1 |
0.0000 |
| 26 |
Alkylating Drug [EPC] |
3 |
0.0000 |
| 27 |
Platelet Aggregation Inhibitor [EPC] |
7 |
0.0000 |
| 28 |
Dihydropyridine Calcium Channel Blocker [EPC] |
4 |
0.0000 |
| 29 |
Histamine-1 Receptor Antagonist [EPC] |
1 |
0.0000 |
| 30 |
Nucleoside Analog Antiviral [EPC] |
1 |
0.0000 |
| 31 |
Nitrate Vasodilator [EPC] |
1 |
0.0000 |
| 32 |
Prostaglandin Analog [EPC] |
1 |
0.0000 |
| 33 |
Purine Antimetabolite [EPC] |
1 |
0.0000 |
| 34 |
Vitamin D [EPC] |
3 |
0.0000 |
| 35 |
Vitamin B12 [EPC] |
3 |
0.0000 |
| 36 |
Proteasome Inhibitor [EPC] |
1 |
0.0000 |
| 37 |
Nonsteroidal Anti-inflammatory Drug [EPC] |
11 |
0.0000 |
| 38 |
HMG-CoA Reductase Inhibitor [EPC] |
3 |
0.0000 |
| 39 |
Angiotensin Converting Enzyme Inhibitor [EPC] |
1 |
0.0000 |
| 40 |
Platinum-based Drug [EPC] |
2 |
0.0000 |
| 41 |
Benzodiazepine [EPC] |
5 |
0.0000 |
| 42 |
Vitamin C [EPC] |
3 |
0.0000 |
| 43 |
alpha-Adrenergic Blocker [EPC] |
1 |
0.0000 |
| 44 |
Insulin Analog [EPC] |
3 |
0.0000 |
| 45 |
Atypical Antipsychotic [EPC] |
3 |
0.0000 |
| 46 |
Loop Diuretic [EPC] |
3 |
0.0000 |
| 47 |
beta-Adrenergic Blocker [EPC] |
2 |
0.0000 |
| 48 |
Aldosterone Antagonist [EPC] |
1 |
0.0000 |
| 49 |
CD20-directed Cytolytic Antibody [EPC] |
2 |
0.0000 |
| 50 |
Janus Kinase Inhibitor [EPC] |
1 |
0.0000 |
| 51 |
Kinase Inhibitor [EPC] |
3 |
0.0000 |
| 52 |
Interferon beta [EPC] |
1 |
0.0000 |
| 53 |
Thiazide Diuretic [EPC] |
1 |
0.0000 |
| 54 |
Mood Stabilizer [EPC] |
1 |
0.0000 |
| 55 |
Anti-epileptic Agent [EPC] |
1 |
0.0000 |
| 56 |
Retinoid [EPC] |
1 |
0.0000 |
| 57 |
Nucleoside Metabolic Inhibitor [EPC] |
1 |
0.0000 |
| 58 |
Osmotic Laxative [EPC] |
1 |
0.0000 |
| 59 |
Corticosteroid [EPC] |
4 |
0.0000 |
| 60 |
Folate Analog Metabolic Inhibitor [EPC] |
1 |
0.0000 |
| 61 |
Interleukin-4 Receptor alpha Antagonist [EPC] |
1 |
0.0000 |